Antioxidant and cholinesterase inhibitory activities of these compounds have been demonstrated in recent metabolomic studies and may be promising for the treatment of diseases related to oxidative stress, such as Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis, and metabolic syndromes, such as diabetes mellitus [30,34,35]. This evidence concerns the gene BCHE and amyotrophic lateral sclerosis.